APA (7th ed.) Citation

SL, H., LG, B., SA, R., CW, H., S, B., P, M., . . . RM, P. (2025). Safety, Tolerability, and Pharmacokinetics of Once-Monthly Oral Islatravir: A Phase 2a Study in Participants at Low Risk for Acquiring Human Immunodeficiency Virus Type 1. The Journal of infectious diseases, 232(5), 1050. https://doi.org/10.1093/infdis/jiaf222

Chicago Style (17th ed.) Citation

SL, Hillier, et al. "Safety, Tolerability, and Pharmacokinetics of Once-Monthly Oral Islatravir: A Phase 2a Study in Participants at Low Risk for Acquiring Human Immunodeficiency Virus Type 1." The Journal of Infectious Diseases 232, no. 5 (2025): 1050. https://doi.org/10.1093/infdis/jiaf222.

MLA (9th ed.) Citation

SL, Hillier, et al. "Safety, Tolerability, and Pharmacokinetics of Once-Monthly Oral Islatravir: A Phase 2a Study in Participants at Low Risk for Acquiring Human Immunodeficiency Virus Type 1." The Journal of Infectious Diseases, vol. 232, no. 5, 2025, p. 1050, https://doi.org/10.1093/infdis/jiaf222.